Risk of tuberculosis among renal transplant recipients receiving rituximab therapy-Reference-Cited by-同舟云学术

Risk of tuberculosis among renal transplant recipients receiving rituximab therapy

Published:2022-10-28 Issue:6 Volume:24 Page:
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transplant Infectious Dis

Author:

Chandrashekhar Praveen¹,Kaul Anupma¹^ORCID,Bhaduaria Dharmendra¹^ORCID,Prasad Narayan¹,Behera Manas¹,Kushwaha Ravi¹,Patel Manas¹^ORCID,Yachha Monika¹,Srivastava Aneesh²

Affiliation:

1. Department of Nephrology and Renal Transplantation Sanjay Gandhi Post‐Graduate Institute of Medical Sciences Lucknow Uttar Pradesh India

2. Department of Urology and Renal Transplantation Sanjay Gandhi Post‐Graduate Institute of Medical Sciences Lucknow Uttar Pradesh India

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13963

Reference16 articles.

1. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

2. Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent

3. Risk of tuberculosis reactivation with rituximab therapy;Alkadi A;Int J Health Sci,2017

4. Tolerability and safety of rituximab (MabThera®)

5. B Cells Moderate Inflammatory Progression and Enhance Bacterial Containment upon Pulmonary Challenge with Mycobacterium tuberculosis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Adverse Events Following Immunosuppressant Administration for Pediatric Patients With Renal Transplants Categorized by Two-Year Age Increments Using the U.S. Food and Drug Administration Adverse Event Reporting System;Cureus;2024-07-24

2. Emerging Therapeutic Options for Refractory Pulmonary Sarcoidosis: The Evidence and Proposed Mechanisms of Action;Journal of Clinical Medicine;2023-12-19